Forty‐seven different mutations, the vast majority predicted to be deleterious for protein synthesis or function, of SOCS1 were detected in 21 patients, of which 12 were classified as non‐GCB and 9 as GCB‐DLBCL (Juskevicius et al, 2017). Here, SOCS1 is linked to diffuse large B-cell lymphoma.